Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Dottorini

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using <sup>123</sup>I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT)S Cascianelli, C Tranfaglia, M L Fravolini, et al.
Minerva Medica|June 2, 2012
[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH]O Testori, M Bagnasco, E Banti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2012
The widened use of exogenous stimulation with recombinant human TSH to treat metastatic thyroid carcinoma in ItalyL Maffioli, L Florimonte, L Fugazzola, et al.
British Journal of Cancer|October 30, 2003
Second primary malignancies in thyroid cancer patientsC Rubino, F de Vathaire, M E Dottorini, et al.
Thyroid : Official Journal of the American Thyroid Association|March 25, 1999
Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablationR Guglielmi, C M Pacella, M E Dottorini, et al.
Endocrine|November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experienceG Mazziotti, A M Formenti, M B Panarotto, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Hellenic Journal of Nuclear Medicine|January 12, 2018
Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using <sup>123</sup>I-FP-CIT brain SPET data by using an artificial neural network classifier, a classification tree (ClT)S Cascianelli, C Tranfaglia, M L Fravolini, et al.
Minerva Medica|June 2, 2012
[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH]O Testori, M Bagnasco, E Banti, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 17, 2012
The widened use of exogenous stimulation with recombinant human TSH to treat metastatic thyroid carcinoma in ItalyL Maffioli, L Florimonte, L Fugazzola, et al.
British Journal of Cancer|October 30, 2003
Second primary malignancies in thyroid cancer patientsC Rubino, F de Vathaire, M E Dottorini, et al.
Thyroid : Official Journal of the American Thyroid Association|March 25, 1999
Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablationR Guglielmi, C M Pacella, M E Dottorini, et al.
Endocrine|November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experienceG Mazziotti, A M Formenti, M B Panarotto, et al.
Pageof 2